Natural history of Upshaw–Schulman syndrome based on ADAMTS13 gene analysis in Japan
- 22 July 2011
- journal article
- review article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 9, 283-301
- https://doi.org/10.1111/j.1538-7836.2011.04341.x
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- aHUS caused by complement dysregulation: new therapies on the horizonPediatric Nephrology, 2010
- Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpuraBlood, 2008
- Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 2006
- Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndromeThe Journal of Pediatrics, 2003
- Thrombotic MicroangiopathiesNew England Journal of Medicine, 2002
- von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndromeBlood, 2002
- von Willebrand Factor—Cleaving Protease and Upshaw-Schulman SyndromeInternational Journal of Hematology, 2002
- Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic PurpuraJournal of Biological Chemistry, 2001
- Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpuraNature, 2001
- A Novel Human Metalloprotease Synthesized in the Liver and Secreted into the Blood: Possibly, the von Willebrand Factor--Cleaving Protease?The Journal of Biochemistry, 2001